0 TSX Venture News - December 11, 2024GFG Announces Proceeds of C$3.7 Million from Warrant Exercise Accelerates Exploration Programs in TimminsNOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES SASKATOON, Saskatchewan, Dec. 11, 2024 (GLOBE NEWSWIRE) — GFG […]Read More
0 NYSE Companies - December 11, 2024Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity SummitHUNTSVILLE, AL, Dec. 11, 2024 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing […]Read More
0 TSX News - December 11, 2024Titan Mining Hits Key Loan Milestone, Executes Financial Deleveraging Strategy for 2025VANCOUVER, British Columbia, Dec. 11, 2024 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX: TI, OTCQB: TIMCF) (“Titan” or the “Company”) […]Read More
0 NYSE Companies - December 11, 2024STMicroelectronics introduces first STM32-ready wireless IoT modules leveraging collaboration with QualcommSTMicroelectronics introduces first STM32-ready wireless IoT modules leveraging collaboration with Qualcomm WiFi6/Bluetooth 5.3/Thread ST67W611M1 modules accelerate development and boosts [...]Read More
0 NASDAQ Companies - December 11, 2024Habib Bank Zurich plc Partners with nCino to Power an Enhanced Digital Experience for its Buy-to-Let Lending BusinessWILMINGTON, N.C., Dec. 11, 2024 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, […]Read More
0 NYSE Companies - December 11, 2024FTI Consulting Continues Expansion of Global Construction Capabilities with Two Senior HiresLONDON, Dec. 11, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the addition of Paul Hirst and Jorge Martínez […]Read More
0 NYSE Companies - December 11, 2024VAALCO Energy, Inc. Secures Rig for 2025/2026 Drilling CampaignHOUSTON, Dec. 11, 2024 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) (“Vaalco” or the “Company”) today announced […]Read More
0 NASDAQ Companies - December 11, 2024Pharming announces positive topline data in pediatric clinical trial of leniolisibMultinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary […]Read More